- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Inc stock price live, this page displays NASDAQ NRIX stock exchange data. View the NRIX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nurix Therapeutics Inc real time stock price chart below.
What Is the Nurix Therapeutics Inc Stock Price Today?
The Nurix Therapeutics Inc stock price today is 16.98.
What Is the Stock Symbol for Nurix Therapeutics Inc?
The stock ticker symbol for Nurix Therapeutics Inc is NRIX.
Is NRIX the Same as $NRIX?
$NRIX is a common way to refer to the Nurix Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Nurix Therapeutics Inc Trade On?
Nurix Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Nurix Therapeutics Inc a Good Stock to Buy?
Determining whether Nurix Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Nurix Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRIX quote. (ISIN: US67080M1036)
What Is the Nurix Therapeutics Inc Stock Price Today?
The Nurix Therapeutics Inc stock price today is 16.98.
What Is the Stock Symbol for Nurix Therapeutics Inc?
The stock ticker symbol for Nurix Therapeutics Inc is NRIX.
Is NRIX the Same as $NRIX?
$NRIX is a common way to refer to the Nurix Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Nurix Therapeutics Inc Trade On?
Nurix Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Nurix Therapeutics Inc a Good Stock to Buy?
Determining whether Nurix Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Nurix Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRIX quote. (ISIN: US67080M1036)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.36
17.11
52 wk Range
8.20
22.50
NRIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.3617.11
52 wk Range
8.2022.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NRIX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
30.24
Upside
+78.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
10 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton’s tyrosine kinase (BTK) degrader, that is in Phase Phase 1a/1b clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1a/1b clinical trials to treat immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in Brisbane, California.
Nurix Therapeutics Inc SWOT Analysis
Market Positioning | Delve into Nurix's competitive stance, upcoming milestones, and the potential impact of successful clinical trials on its market valuation |
Strategic Expansion | Learn about Nurix's move into autoimmune diseases, broadening its market reach and diversifying its portfolio beyond oncology |
Financial Landscape | Despite negative EPS forecasts, analysts maintain positive outlooks with price targets ranging from $16 to $41, suggesting potential upside |
Pipeline Promise | Explore Nurix's innovative protein regulation technology and its advancing clinical pipeline, focusing on cancer and immune disorders treatments |
Compare NRIX to Peers and Sector
Metrics to compare | NRIX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNRIXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.8x | −4.3x | −0.5x | |
PEG Ratio | 0.45 | −0.12 | 0.00 | |
Price / Book | 3.6x | 2.7x | 2.6x | |
Price / LTM Sales | 24.0x | 64.8x | 3.2x | |
Upside (Analyst Target) | 80.4% | 35.4% | 47.6% | |
Fair Value Upside | Unlock | 4.8% | 6.1% | Unlock |
Analyst Ratings
17 Buy
0 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 30.24
(+78.06% Upside)
Earnings
Latest Release
Apr 08, 2026
EPS / Forecast
-0.79 / -0.76
Revenue / Forecast
6.25M / 14.25M
People Also Watch
FAQ
What Is the Nurix (NRIX) Stock Price Today?
The Nurix stock price today is 16.98 USD.
What Stock Exchange Does Nurix Trade On?
Nurix is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Nurix?
The stock symbol for Nurix is "NRIX."
What Is the Nurix Market Cap?
As of today, Nurix market cap is 1.75B USD.
What Is Nurix's Earnings Per Share (TTM)?
The Nurix EPS (TTM) is -3.17.
When Is the Next Nurix Earnings Date?
Nurix will release its next earnings report on Jul 09, 2026.
From a Technical Analysis Perspective, Is NRIX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Nurix Stock Split?
Nurix has split 0 times.
How Many Employees Does Nurix Have?
Nurix has 317 employees.
What is the current trading status of Nurix (NRIX)?
As of Apr 15, 2026, Nurix (NRIX) is trading at a price of 16.98 USD, with a previous close of 16.30 USD. The stock has fluctuated within a day range of 16.36 USD to 17.11 USD, while its 52-week range spans from 8.20 USD to 22.50 USD.
What Is Nurix (NRIX) Price Target According to Analysts?
The average 12-month price target for Nurix is 30.24 USD, with a high estimate of 41 USD and a low estimate of 23 USD. 17 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +78.06% Upside potential.
What Is the NRIX Premarket Price?
NRIX's last pre-market stock price is 16.55 USD. The pre-market share volume is 2,250.00, and the stock has decreased by 0.25, or 1.53%.
What Is the NRIX After Hours Price?
NRIX's last after hours stock price is 16.26 USD, the stock has decreased by -0.71, or -4.18%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.